ADIPOQ and metabolic syndrome: Consequently, the negative correlations of adiponectin and the adiponectin/TNF-α ratio with FBG and TG that observed in the current study could be addressed as the protective effects of adiponectin against metabolic syndrome complications in women with GDM.